- call +1-201-465-4211
- email sales@mrinsights.biz
A blood sugar lancet is a small medical device used in capillary blood sampling. It looks similar to a scalpel but has a double-edged needle or blade. Blood sugar lancets are used to make minuscule punctures to obtain blood samples and are mostly disposable. The blood sugar lancet market is a part of the global diabetes market as they are commonly used to measure blood glucose levels. The depth of the skin to be penetrated can be adjusted for various levels of skin thickness. Some devices can even be used to measure the acid base status of an unborn foetus.
Scope of the Report:
This report focuses on the Blood Sugar Lancets in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As per the International Diabetes Federation, it is estimated that nearly 642 million people will suffer from diabetes by the year 2040. This amounts to nearly 1 in 10 adults. They are anticipated to be the biggest driver of the blood sugar lancet market in the coming decade. Diabetes is far more likely to occur in obese or senior citizens in any country. Western countries are already troubled by both these health predicaments. There is also an increasing number of both type 1 and type 2 cases of diabetes being reported in children and thus, governments will be under increasing pressure to tackle the issue head one. The blood sugar lancet market will allow people to monitor their glucose level, keep it under control and take the medication as and when required.
The second driver of the blood sugar lancet market is the reimbursement options available, especially in developed countries. These devices are typically replaced every six to eight months which makes them expensive in the long run. Thus, patients prefer health insurance plans that cover most of the device expenditure. These plans also provide coverage for glucose test strips, glucose meters and diabetes testing supplies. In the U.S. alone, Medicare covers almost 80% of the cost of blood glucose monitoring devices like blood sugar lancets. The American Association of Diabetes Educators has also published a reimbursement procedure for primary caregivers, which categorically states that Medicare will reimburse medical service costs of diabetic patients.
The worldwide market for Blood Sugar Lancets is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
Roche
AgaMatrix
Nova Biomedical
Integrity Applications
Medisana
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Disposable
Non-Disposable
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
There are 15 Chapters to deeply display the global Blood Sugar Lancets market.
Chapter 1, to describe Blood Sugar Lancets Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Blood Sugar Lancets, with sales, revenue, and price of Blood Sugar Lancets, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Blood Sugar Lancets, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Blood Sugar Lancets market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Blood Sugar Lancets sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Blood Sugar Lancets Introduction
1.2 Market Analysis by Type
1.2.1 Disposable
1.2.2 Non-Disposable
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Blood Sugar Lancets Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Blood Sugar Lancets Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AgaMatrix
2.3.1 Business Overview
2.3.2 Blood Sugar Lancets Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AgaMatrix Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Nova Biomedical
2.4.1 Business Overview
2.4.2 Blood Sugar Lancets Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Nova Biomedical Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Integrity Applications
2.5.1 Business Overview
2.5.2 Blood Sugar Lancets Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Integrity Applications Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medisana
2.6.1 Business Overview
2.6.2 Blood Sugar Lancets Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medisana Blood Sugar Lancets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Blood Sugar Lancets Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Blood Sugar Lancets Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Blood Sugar Lancets Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Blood Sugar Lancets Manufacturer Market Share in 2017
3.3.2 Top 6 Blood Sugar Lancets Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Blood Sugar Lancets Market Analysis by Regions
4.1 Global Blood Sugar Lancets Sales, Revenue and Market Share by Regions
4.1.1 Global Blood Sugar Lancets Sales and Market Share by Regions (2013-2018)
4.1.2 Global Blood Sugar Lancets Revenue and Market Share by Regions (2013-2018)
4.2 North America Blood Sugar Lancets Sales and Growth Rate (2013-2018)
4.3 Europe Blood Sugar Lancets Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Blood Sugar Lancets Sales and Growth Rate (2013-2018)
4.5 South America Blood Sugar Lancets Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Blood Sugar Lancets Sales and Growth Rate (2013-2018)
5 North America Blood Sugar Lancets by Countries
5.1 North America Blood Sugar Lancets Sales, Revenue and Market Share by Countries
5.1.1 North America Blood Sugar Lancets Sales and Market Share by Countries (2013-2018)
5.1.2 North America Blood Sugar Lancets Revenue and Market Share by Countries (2013-2018)
5.2 United States Blood Sugar Lancets Sales and Growth Rate (2013-2018)
5.3 Canada Blood Sugar Lancets Sales and Growth Rate (2013-2018)
5.4 Mexico Blood Sugar Lancets Sales and Growth Rate (2013-2018)
6 Europe Blood Sugar Lancets by Countries
6.1 Europe Blood Sugar Lancets Sales, Revenue and Market Share by Countries
6.1.1 Europe Blood Sugar Lancets Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Blood Sugar Lancets Revenue and Market Share by Countries (2013-2018)
6.2 Germany Blood Sugar Lancets Sales and Growth Rate (2013-2018)
6.3 UK Blood Sugar Lancets Sales and Growth Rate (2013-2018)
6.4 France Blood Sugar Lancets Sales and Growth Rate (2013-2018)
6.5 Russia Blood Sugar Lancets Sales and Growth Rate (2013-2018)
6.6 Italy Blood Sugar Lancets Sales and Growth Rate (2013-2018)
7 Asia-Pacific Blood Sugar Lancets by Countries
7.1 Asia-Pacific Blood Sugar Lancets Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Blood Sugar Lancets Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Blood Sugar Lancets Revenue and Market Share by Countries (2013-2018)
7.2 China Blood Sugar Lancets Sales and Growth Rate (2013-2018)
7.3 Japan Blood Sugar Lancets Sales and Growth Rate (2013-2018)
7.4 Korea Blood Sugar Lancets Sales and Growth Rate (2013-2018)
7.5 India Blood Sugar Lancets Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Blood Sugar Lancets Sales and Growth Rate (2013-2018)
8 South America Blood Sugar Lancets by Countries
8.1 South America Blood Sugar Lancets Sales, Revenue and Market Share by Countries
8.1.1 South America Blood Sugar Lancets Sales and Market Share by Countries (2013-2018)
8.1.2 South America Blood Sugar Lancets Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Blood Sugar Lancets Sales and Growth Rate (2013-2018)
8.3 Argentina Blood Sugar Lancets Sales and Growth Rate (2013-2018)
8.4 Colombia Blood Sugar Lancets Sales and Growth Rate (2013-2018)
9 Middle East and Africa Blood Sugar Lancets by Countries
9.1 Middle East and Africa Blood Sugar Lancets Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Blood Sugar Lancets Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Blood Sugar Lancets Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Blood Sugar Lancets Sales and Growth Rate (2013-2018)
9.3 UAE Blood Sugar Lancets Sales and Growth Rate (2013-2018)
9.4 Egypt Blood Sugar Lancets Sales and Growth Rate (2013-2018)
9.5 Nigeria Blood Sugar Lancets Sales and Growth Rate (2013-2018)
9.6 South Africa Blood Sugar Lancets Sales and Growth Rate (2013-2018)
10 Global Blood Sugar Lancets Market Segment by Type
10.1 Global Blood Sugar Lancets Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Blood Sugar Lancets Sales and Market Share by Type (2013-2018)
10.1.2 Global Blood Sugar Lancets Revenue and Market Share by Type (2013-2018)
10.2 Disposable Sales Growth and Price
10.2.1 Global Disposable Sales Growth (2013-2018)
10.2.2 Global Disposable Price (2013-2018)
10.3 Non-Disposable Sales Growth and Price
10.3.1 Global Non-Disposable Sales Growth (2013-2018)
10.3.2 Global Non-Disposable Price (2013-2018)
11 Global Blood Sugar Lancets Market Segment by Application
11.1 Global Blood Sugar Lancets Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Blood Sugar Lancets Market Forecast (2018-2023)
12.1 Global Blood Sugar Lancets Sales, Revenue and Growth Rate (2018-2023)
12.2 Blood Sugar Lancets Market Forecast by Regions (2018-2023)
12.2.1 North America Blood Sugar Lancets Market Forecast (2018-2023)
12.2.2 Europe Blood Sugar Lancets Market Forecast (2018-2023)
12.2.3 Asia-Pacific Blood Sugar Lancets Market Forecast (2018-2023)
12.2.4 South America Blood Sugar Lancets Market Forecast (2018-2023)
12.2.5 Middle East and Africa Blood Sugar Lancets Market Forecast (2018-2023)
12.3 Blood Sugar Lancets Market Forecast by Type (2018-2023)
12.3.1 Global Blood Sugar Lancets Sales Forecast by Type (2018-2023)
12.3.2 Global Blood Sugar Lancets Market Share Forecast by Type (2018-2023)
12.4 Blood Sugar Lancets Market Forecast by Application (2018-2023)
12.4.1 Global Blood Sugar Lancets Sales Forecast by Application (2018-2023)
12.4.2 Global Blood Sugar Lancets Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Blood Sugar Lancets Picture
Table Product Specifications of Blood Sugar Lancets
Figure Global Sales Market Share of Blood Sugar Lancets by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
